Flu and pulmonary fibrosis

Lung India

Volumn 30, Issue 2, 2013, Pages 95-96

  Sharma, Bharat Bhushan ^a   Singh, Virendra ^a  

^a SMS MEDICAL COLLEGE   (India)

Author keywords

[No Author keywords available]

Indexed keywords

AWARENESS; COMPUTER ASSISTED TOMOGRAPHY; CROWDING; EDITORIAL; FIBROSING ALVEOLITIS; GENE EXPRESSION PROFILING; HUMAN; INFLUENZA; LUNG FIBROSIS; RISK FACTOR; SANITATION;

EID: 84876927557     PISSN: 09702113     EISSN: 0974598X     Source Type: Journal    
DOI: 10.4103/0970-2113.110412     Document Type: Editorial

References (15)

1. Whitley RJ, Boucher CA, Lina B, Nguyen-Van-Tam JS, Osterhaus A, Schutten M, et al. Global assessment of resistance to neuraminidase inhibitors, 2008-2011: The Influenza Resistance Information Study (IRIS). Clin Infect Dis 2013; Available from: http://www.cid.oxfordjournals.org/content/early/2013/02/ 27/cid.cis1220.full [Last accessed on 2013 Mar 19].
2. Govorkova EA, Baranovich T, Seiler P, Armstrong J, Burnham A, Guan Y, et al. Antiviral resistance among highly pathogenic influenza A (H5N1) viruses isolated worldwide in 2002-2012 shows need for continued monitoring. Antiviral Res 2013; Available from: http://www.sciencedirect.com/science/article/pii/ S0166354213000508 [Last accessed on 2013 Mar 19].
3. Centers for Disease Control and Prevention (CDC). Update: Influenza activity-United States, September 30-November 24, 2012. J Med Econ 2013;16:264-77.
4. Mauskopf J, Klesse M, Lee S, Herrera-Taracena G. The burden of influenza complications in different high-risk groups: A targeted literature review. J Med Econ 2013;16:264-77.
5. Singh V, Sharma BB, Patel V. Pulmonary sequelae in a patient recovered from swine flu. Lung India 2012;29:277-9.
6. Selman M, Pardo A, Barrera L, Estrada A, Watson SR, Wilson K, et al. Gene expression profiles distinguish idiopathic pulmonary fibrosis from hypersensitivity pneumonitis. Am J Respir Crit Care Med 2006;173:188-98.
7. Taskar VS, Coultas DB. Is idiopathic pulmonary fibrosis an environmental disease? Proc Am Thorac Soc 2006;3:293-8.
8. Naik PK, Moore BB. Viral infection and aging as cofactors for the development of pulmonary fibrosis. Expert Rev Respir Med 2010;4:759-71.
9. Qiao J, Zhang M, Bi J, Wang X, Deng G, He G, et al. Pulmonary fibrosis induced by H5N1 viral infection in mice. Respir Res 2009;10:107.
10. Agostini C, Gurrieri C. Chemokine/cytokine cocktail in idiopathic pulmonary fibrosis. Proc Am Thorac Soc 2006;3:357-63.
11. Wen Y, Deng BC, Zhou Y, Wang Y, Cui W, Wang W, et al. Immunological features in patients with pneumonitis due to influenza A H1N1 infection. J Investig Allergol Clin Immunol 2011;21:44-50.
12. Xing Z, Tremblay GM, Sime PJ, Gauldie J. Overexpression of granulocyte-macrophage colony-stimulating factor induces pulmonary granulation tissue formation and fibrosis by induction of transforming growth factor-beta 1 and myofibroblast accumulation. Am J Pathol 1997;150:59-66.
13. Jakab GJ. Sequential virus infections, bacterial superinfections, and fibrogenesis. Am Rev Respir Dis 1990;142:374-9.
14. Joob B, Wiwanitkit V. Pulmonary sequelae of swine flu. Lung India 2013;30:81-2.
15. Zanetti G, Hochhegger H, Marchiori E. Organizing pneumonia as a pulmonary sequel of swine flu. Lung India 2013;30:71.